Ana Navarro

1.9k total citations
55 papers, 1.4k citations indexed

About

Ana Navarro is a scholar working on Physiology, Immunology and Allergy and Pharmacology. According to data from OpenAlex, Ana Navarro has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Physiology, 24 papers in Immunology and Allergy and 11 papers in Pharmacology. Recurrent topics in Ana Navarro's work include Allergic Rhinitis and Sensitization (24 papers), Asthma and respiratory diseases (23 papers) and Pain Mechanisms and Treatments (13 papers). Ana Navarro is often cited by papers focused on Allergic Rhinitis and Sensitization (24 papers), Asthma and respiratory diseases (23 papers) and Pain Mechanisms and Treatments (13 papers). Ana Navarro collaborates with scholars based in Spain, United States and Qatar. Ana Navarro's co-authors include Javier Rejas, Concepción Pérez, Robert M. Kaplan, C. Colás, Karen L. Senn, Ignacio Dávila, Joaquim Mullol, Antonio Valero, Antonio Valero and Santiago Quirce and has published in prestigious journals such as PLoS ONE, American Journal of Public Health and Journal of Allergy and Clinical Immunology.

In The Last Decade

Ana Navarro

52 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ana Navarro

Since Specialization

Citations

This map shows the geographic impact of Ana Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Navarro more than expected).

Fields of papers citing papers by Ana Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Navarro. The network helps show where Ana Navarro may publish in the future.

Co-authorship network of co-authors of Ana Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Navarro. A scholar is included among the top collaborators of Ana Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Navarro. Ana Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of post‐stroke aphasia on functional communication, quality of life, perception of health and depression: A case–control study 2023 ·European Journal of Neurology ·(unknown), (unknown), (unknown), Ana Navarro, (unknown), (unknown), Elena de Celis, María Alonso de Leciñana, (unknown), Ricardo Rigual, Gerardo Ruiz‐Ares, Jorge Rodríguez‐Pardo, Javier Virúes‐Ortega, Blanca Fuentes	4
2	Update on Interventional Management of Neuropathic Pain: A Delphi Consensus of the Spanish Pain Society Neuropathic Pain Task Force 2022 ·Medicina ·(unknown), Rafael Gálvez, (unknown), Ana Navarro, Dolores Ochoa, Concepción Pérez	3
3	Validation of the DECA criteria for allergic conjunctivitis severity and control 2020 ·Clinical and Translational Allergy ·(unknown), Ana Navarro, C. Colás, A del Cuvillo, J. Sastre, Joaquim Mullol, Antonio Valero	6
4	Late effects awareness website for pediatric survivors of acute lymphocytic leukemia 2018 ·PLoS ONE ·Hillary Klonoff‐Cohen, Ana Navarro, Elizabeth A. Klonoff	4
5	The Arm’s Length Standard and Tax Justice: Reflections on the Present and the Future of Transfer Pricing 2018 ·World Tax Journal ·Ana Navarro	5
6	Relationship between respiratory and food allergy and evaluation of preventive measures 2015 ·Allergologia et Immunopathologia ·Francisco Vega, Carlos Panizo, M T Dordal, (unknown), (unknown), Antonio Valero, M C Sánchez, Carmen Rondón, J Montoro, Víctor Matheu, M Lluch‐Bernal, (unknown), B Fernández-Parra, A del Cuvillo, Ignacio Dávila, C. Colás, Paloma Campo, E. Antón, Ana Navarro	9
7	A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study) 2013 ·Allergy Asthma and Clinical Immunology ·Pedro Ojeda, Núria Piqué, (unknown), Julio Delgado, Feo F, J Igea, Ana Navarro, José M. Rivera, (unknown), (unknown), Morgan Andersson	15
8	The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification 2012 ·Rhinology Journal ·Antonio Valero, Rosa Muñoz‐Cano, J. Sastre, Ana Navarro, (unknown), Ignacio Dávila, A del Cuvillo, C. Colás, I. Antépara, Iñaki Izquierdo, Joaquim Mullol	21
9	The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification 2012 ·Rhinology Journal ·Antonio Valero, Rosa Muñoz‐Cano, J. Sastre, Ana Navarro, (unknown), Ignacio Dávila, A del Cuvillo, C. Colás, I. Antépara, Iñaki Izquierdo, Joaquim Mullol	19
10	Costs and Health Resources Utilization Following Switching to Pregabalin in Individuals with Gabapentin‐Refractory Neuropathic Pain: A post hoc Analysis 2011 ·Pain Practice ·Ana Navarro, (unknown), Concepción Pérez, Xavier Masramón, Javier Rejas	10
11	A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings 2011 ·BMC Neurology ·Ana Navarro, (unknown), Concepción Pérez, (unknown), Javier Rejas	36
12	Prevalencia y características de la rinitis en pacientes asmáticos de las consultas de Atención Primaria, Alergología y Neumología en España (Estudio AIR) 2010 ·Medicina Clínica ·José A. García del Castillo, Ana Navarro, Santiago Quirce, (unknown), Luis García‐Marcos, Berta Juliá, Antonio Valero, Joaquim Mullol	7
13	Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study 2010 ·Clinical Therapeutics ·Concepción Pérez, Ana Navarro, (unknown), Xavier Masramón, Javier Rejas	36
14	Patient-reported Outcomes in Subjects with Neuropathic Pain Receiving Pregabalin: Evidence from Medical Practice in Primary Care Settings 2010 ·Pain Medicine ·Ana Navarro, (unknown), Concepción Pérez, (unknown), Javier Rejas	31
15	Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis 2010 ·Allergy ·Antonio Valero, Montse Ferrer, Eva Baró, J. Sastre, Ana Navarro, E Martí-Guadaño, Ignacio Dávila, A del Cuvillo, C. Colás, I. Antépara, Jordi Alonso, (unknown), Iñaki Izquierdo, Joaquim Mullol	29
16	Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergológica-2005. 2009 ·PubMed ·Ana Navarro, C. Colás, E. Antón, J. Condé, Ignacio Dávila, M T Dordal, (unknown), (unknown), M Lluch‐Bernal, Víctor Matheu, J Montoro, Carmen Rondón, M C Sánchez, Antonio Valero	46
17	Diffusion of cancer education information through a Latino community health advisor program 2007 ·Preventive Medicine ·Ana Navarro, Rema Raman, (unknown), Oralia Loza	25
18	Estrategias de prevención y control de la Brucelosis humana en el Perú 2005 ·Revista Peruana de Medicina Experimental y Salud Pública ·Ana Navarro, (unknown), (unknown)	1
19	Simulated effect of tobacco tax variation on population health in California 2001 ·American Journal of Public Health ·Robert M. Kaplan, Christopher F. Ake, Sherry Emery, Ana Navarro	30
20	Smoking status by proxy and self report: rate of agreement in different ethnic groups 1999 ·Tobacco Control ·Ana Navarro	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact